Vericel to Host Third-Quarter 2016 Earnings Webcast and Conference Call on November 7, 2016
Oct 31, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cellular therapies for the treatment of severe diseases and conditions, today announced the following...
Vericel to Host Third-Quarter 2016 Earnings Webcast and Conference Call on November 7, 2016
Oct 31, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cellular therapies for the treatment of severe diseases and conditions, today announced the following...
Oct 31, 2016 12:01 pm UTC| Business
3rd Quarter vs. 2ndQuarter 2016 Highlights: Earnings of $34.7 million, or $0.25 per common shareLoan growth of 4.1% annualizedTangible book value1 increase of 2.4%Stable Core Net Interest Margin1Decline in Noninterest...
Oct 31, 2016 12:01 pm UTC| Business
3rd Quarter vs. 2ndQuarter 2016 Highlights: Earnings of $34.7 million, or $0.25 per common shareLoan growth of 4.1% annualizedTangible book value1 increase of 2.4%Stable Core Net Interest Margin1Decline in Noninterest...
CCA Awarded New Management Contract at the Cibola County Corrections Center
Oct 31, 2016 12:01 pm UTC| Business
NASHVILLE, Tenn., Oct. 31, 2016 -- Corrections Corporation of America (NYSE:CXW) (the “Company” or “CCA”), which announced on October 28, 2016, that it is rebranding its corporate enterprise as "CoreCivic" later in...
CCA Awarded New Management Contract at the Cibola County Corrections Center
Oct 31, 2016 12:01 pm UTC| Business
NASHVILLE, Tenn., Oct. 31, 2016 -- Corrections Corporation of America (NYSE:CXW) (the “Company” or “CCA”), which announced on October 28, 2016, that it is rebranding its corporate enterprise as "CoreCivic" later in...
Oct 31, 2016 12:01 pm UTC| Business
Data Underscore Potential of SVP-Rapamycin to Improve Therapeutic Benefit and Tolerability by Mitigating Unwanted Human Immune ResponsesResults Presented at the Immunogenicity and Bioassay Summit WATERTOWN, Mass., Oct. ...